Hinge Health, Inc. (HNGE) vs Praxis Precision Medicines, Inc. (PRAX)
A side-by-side comparison of Hinge Health, Inc. and Praxis Precision Medicines, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HNGE
Hinge Health, Inc.
$97.75HealthcareDelayed quote: Oct 6, 2026, 2:00 PM EDT
PRAX
Praxis Precision Medicines, Inc.
$275.87HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
Total return — HNGE vs PRAX
growth of $100 · dividends reinvested · last 1yHNGE +161.8% (+161.8%/yr)PRAX +640.2% (+640.2%/yr)PRAX compounded faster over this window
HNGE PRAX
HNGE vs PRAX: by the numbers
- •PRAX is the larger company ($7.69B vs $7.56B market cap).
- •HNGE is profitable (15.15% net margin) while PRAX runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | HNGE | PRAX |
|---|---|---|
| P/E ratio | 75.98 | N/A |
| Forward P/E | 42.15 | N/A |
| P/S ratio | 10.50 | N/A |
| P/B ratio | 21.97 | 5.74 |
| EV / EBITDA | 74.56 | N/A |
| FCF yield | 3.80% | N/A |
Profitability
| Metric | HNGE | PRAX |
|---|---|---|
| Gross margin | 84.52% | 0.00% |
| Operating margin | -92.94% | 0.00% |
| Net margin | 15.15% | 0.00% |
| ROE | 31.68% | -25.29% |
| ROIC | 26.62% | -28.18% |
Growth (annualized)
| Metric | HNGE | PRAX |
|---|---|---|
| Total return CAGR (5Y) | N/A | -0.21% |
Frequently asked
- Is HNGE or PRAX more profitable?
- HNGE runs the higher net margin — HNGE at 15.15% versus PRAX at 0.00%.
Go deeper
Dig into the metrics
Hinge Health P/E ratioHinge Health ROEPraxis Precision Medicines ROEHinge Health operating marginPraxis Precision Medicines operating marginHinge Health revenue growthPraxis Precision Medicines revenue growthHinge Health free cash flowPraxis Precision Medicines free cash flow
Hinge Health & Praxis Precision Medicines appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.